Table 1.

Recommendations by category from the MTB for all patients analyzed (n = 613).

Recommendation Category	Number of Recommendations	Proportion of Patients Receiving Recommendations 1 (%)
Clinical trial	262	43
Standard therapy	311	51
Off-label therapy	84	14
Germline testing and genetic counseling	143	23
Subspecialty multidisciplinary tumor board review	18	3
Advice for classifying tumor of unknown origin	13	2

¹ Patients could have more than one recommendation. Abbreviations: MTB, molecular tumor board.